Atlas Trials

A Safety, Pharmacokinetics and Efficacy Study of MAU868 for the Treatment of BK Viremia in Kidney Transplant Recipients

Clinical trial NCT04294472 · COMPLETED

Trial details

NCT number
NCT04294472
Sponsor
Vera Therapeutics, Inc.
Status
COMPLETED
Phase
Phase 2
Study type
INTERVENTIONAL
BK Virus Infection
Start date
2020-08-05
Primary completion
2022-02-10
Enrollment
30

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.